FOI Request 222 1415

The Drug Utilisation Sub Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) utilisation analysis of testosterone considered at the October 2012 meeting of DUSC.

Page last updated: 27 May 2015

FOI 222 1415 Document 1 (PDF 533 KB)